Studies conducted by Héma-Québec in collaboration with the Institut national de santé publique (INSPQ), and in partnership with the COVID-19 Immunity Task Force (CITF), aim to measure the progression of immunity in the population.
CLINICAL STUDY ON CONVALESCENT PLASMA
Héma-Québec was involved in a national clinical trial project, with the objective of developing a passive immunization program for treating people with COVID-19.
PLASMA DONOR BIOBANK
The biobank aims to measure the impact of vaccination, or infection, on the immune response.